MYC and non-small cell lung carcinoma: For example, the fifth ranked regulator MYC was recently proved to mitigate its oncogenic activity by chaperone-mediated autophagy (CMA) regulation [29] and the ninth ranked regulator XIST was determined to increase autophagy activity in non-small-cell lung cancer by regulation of ATG7 [30].